158 related articles for article (PubMed ID: 15498031)
1. Interferon-gamma-modified dendritic cells suppress B cell function and ameliorate the development of experimental autoimmune myasthenia gravis.
Adikari SB; Lian H; Link H; Huang YM; Xiao BG
Clin Exp Immunol; 2004 Nov; 138(2):230-6. PubMed ID: 15498031
[TBL] [Abstract][Full Text] [Related]
2. Protective potential of experimental autoimmune myasthenia gravis in Lewis rats by IL-10-modified dendritic cells.
Duan RS; Adikari SB; Huang YM; Link H; Xiao BG
Neurobiol Dis; 2004 Jul; 16(2):461-7. PubMed ID: 15193302
[TBL] [Abstract][Full Text] [Related]
3. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
Xiao BG; Duan RS; Zhu WH; Lu CZ
Cell Immunol; 2006 Jun; 241(2):95-101. PubMed ID: 17005165
[TBL] [Abstract][Full Text] [Related]
4. Induction of peripheral tolerance to experimental autoimmune myasthenia gravis by acetylcholine receptor-pulsed dendritic cells.
Xiao BG; Duan RS; Link H; Huang YM
Cell Immunol; 2003 May; 223(1):63-9. PubMed ID: 12914759
[TBL] [Abstract][Full Text] [Related]
5. Dendritic cells exposed in vitro to TGF-beta1 ameliorate experimental autoimmune myasthenia gravis.
Yarilin D; Duan R; Huang YM; Xiao BG
Clin Exp Immunol; 2002 Feb; 127(2):214-9. PubMed ID: 11876742
[TBL] [Abstract][Full Text] [Related]
6. Modulation of immune responses and suppression of experimental autoimmune myasthenia gravis by surgical denervation of the spleen.
Bakhiet M; Yu LY; Ozenci V; Khan A; Shi FD
Clin Exp Immunol; 2006 May; 144(2):290-8. PubMed ID: 16634803
[TBL] [Abstract][Full Text] [Related]
7. Role for interferon-gamma in rat strains with different susceptibility to experimental autoimmune myasthenia gravis.
Wang HB; Shi FD; Li H; van der Meide PH; Ljunggren HG; Link H
Clin Immunol; 2000 May; 95(2):156-62. PubMed ID: 10779409
[TBL] [Abstract][Full Text] [Related]
8. T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
Wang ZY; Qiao J; Melms A; Link H
Cell Immunol; 1993 Dec; 152(2):394-404. PubMed ID: 8258147
[TBL] [Abstract][Full Text] [Related]
9. Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG).
Ma CG; Zhang GX; Xiao BG; Link H
Clin Exp Immunol; 1996 Jun; 104(3):509-16. PubMed ID: 9099937
[TBL] [Abstract][Full Text] [Related]
10. Activation of the adenosine A2A receptor attenuates experimental autoimmune myasthenia gravis severity.
Li N; Mu L; Wang J; Zhang J; Xie X; Kong Q; Tang W; Yao X; Liu Y; Wang L; Wang G; Wang D; Jin L; Sun B; Li H
Eur J Immunol; 2012 May; 42(5):1140-51. PubMed ID: 22539289
[TBL] [Abstract][Full Text] [Related]
11. Antigen-specific T cell functions are suppressed over the estrogen-dendritic cell-indoleamine 2,3-dioxygenase axis.
Xiao BG; Liu X; Link H
Steroids; 2004 Sep; 69(10):653-9. PubMed ID: 15465110
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines.
Li XL; Liu Y; Cao LL; Li H; Yue LT; Wang S; Zhang M; Li XH; Dou YC; Duan RS
Mol Cell Neurosci; 2013 Sep; 56():85-95. PubMed ID: 23541702
[TBL] [Abstract][Full Text] [Related]
13. Anti-TNF-alpha antibodies suppress the development of experimental autoimmune myasthenia gravis.
Duan RS; Wang HB; Yang JS; Scallon B; Link H; Xiao BG
J Autoimmun; 2002 Dec; 19(4):169-74. PubMed ID: 12473237
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 10 aggravates experimental autoimmune myasthenia gravis through inducing Th2 and B cell responses to AChR.
Zhang GX; Xiao BG; Yu LY; van der Meide PH; Link H
J Neuroimmunol; 2001 Feb; 113(1):10-8. PubMed ID: 11137572
[TBL] [Abstract][Full Text] [Related]
15. T-cell immunity to acetylcholine receptor and its subunits in Lewis rats over the course of experimental autoimmune myasthenia gravis.
Wang ZY; Link H; Huang WX
Scand J Immunol; 1993 May; 37(5):615-22. PubMed ID: 7683442
[TBL] [Abstract][Full Text] [Related]
16. Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice.
Ulusoy C; Çavuş F; Yılmaz V; Tüzün E
Immunol Invest; 2017 Jul; 46(5):490-499. PubMed ID: 28375749
[TBL] [Abstract][Full Text] [Related]
17. Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis.
Wang ZY; Link H; Ljungdahl A; Höjeberg B; Link J; He B; Qiao J; Melms A; Olsson T
Cell Immunol; 1994 Sep; 157(2):353-68. PubMed ID: 7520837
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of IFN-gamma, IL-10, and TGF-beta-modulated dendritic cells on immune response in Lewis rats.
Duan RS; Link H; Xiao BG
J Clin Immunol; 2005 Jan; 25(1):50-6. PubMed ID: 15742157
[TBL] [Abstract][Full Text] [Related]
19. Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals.
Shi FD; Bai XF; Li HL; Huang YM; Van der Meide PH; Link H
Clin Exp Immunol; 1998 Mar; 111(3):506-12. PubMed ID: 9528890
[TBL] [Abstract][Full Text] [Related]
20. Exosomes derived from atorvastatin-modified bone marrow dendritic cells ameliorate experimental autoimmune myasthenia gravis by up-regulated levels of IDO/Treg and partly dependent on FasL/Fas pathway.
Li XL; Li H; Zhang M; Xu H; Yue LT; Zhang XX; Wang S; Wang CC; Li YB; Dou YC; Duan RS
J Neuroinflammation; 2016 Jan; 13():8. PubMed ID: 26757900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
